Nuventra Pharma Sciences is excited to announce the opening of a new office in Broomfield, Colorado, which is located in the Greater Denver Area. With a focus on meeting the clinical pharmacology and pharmacokinetic needs of biotech and pharmaceutical companies, Nuventra’s strategic plan includes expansion into the industry hotspots throughout the world.
“Nuventra’s growth is attributed to our excellent staff, corporate culture, and our focused business model that makes us the go-to consulting firm for the industry’s pharmacokinetic needs,” says Nuventra’s CEO and President, Geoffrey Banks, Ph.D., adding, “We have a team of senior clinical pharmacology and pharmacokinetic experts, most with 15 to 30 years of drug development experience, and plan to continue adding more talent and offices throughout the US and globally.”
Nuventra has experienced steady growth over the past several years, recently also opening a new office in Philadelphia, PA. It has grown its workforce from just a few employees to now over 40. Nuventra has also recently been named one of the fastest growing private companies in America by Inc. Magazine, as well as the sixth fastest growing company in North Carolina’s health sector. Nuventra Pharma Sciences has a global reach, consulting with biotech and pharmaceutical clients all over the world, ranging from top tier multi-national pharmaceutical companies to venture-backed, small biotechnology and pharma companies.
More About Nuventra
Founded in 2008, Nuventra is the pharmaceutical industry’s go-to resource for clinical pharmacology, pharmacokinetic, and pharmacometric consulting services. Nuventra gives pharmaceutical companies and CROs rare access to a hands-on team of industry-leading consultants experienced in complex studies and analyses. We embrace the notion that simplicity and clarity lead to good decisions by taking complex pharmacokinetic and pharmacometric principles and making them understandable and usable for common sense drug development. Nuventra’s flexible business structure enables us to integrate with our clients and help them maximize the potential of clinical pharmacology studies and pharmacokinetic analyses to pave the way toward marketing approval.